NOUVEAU VIRUS DE LA VACCINE GÉNÉTIQUEMENT MODIFIÉ

• 收藏
• 分享

专利权人:

Astellas Pharma Inc.;National University Corporation Tottori University

发明人:

NAKAO, Shinsuke,KAWASE, Tatsuya,NAKAMURA, Takafumi

申请号：

EP17806608

公开号：

EP3480307A4

申请日:

2017.05.29

申请国别(地区):

EP

年份:

2020

代理人:

摘要：

[Technical Problem] The present invention provides a genetically recombinant vaccinia virus effective in preventing or treating cancer. [Solution to Problem] Specifically, the present invention provides a vaccinia virus comprising two polynucleotides, a polynucleotide encoding IL-7 and a polynucleotide encoding IL-12； a combination kit of two vaccinia viruses, a vaccinia virus comprising a polynucleotide encoding IL-7 and a vaccinia virus comprising a polynucleotide encoding IL-12； and use of the two vaccinia viruses in combination.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/